Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression.
Activation fragments
cancer
clear cell renal cell carcinoma
complement proteins
complement system
humoral complementomics
plasma
Journal
Oncoimmunology
ISSN: 2162-402X
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
18
3
2024
pubmed:
15
3
2024
entrez:
15
3
2024
Statut:
epublish
Résumé
Despite the progress of anti-cancer treatment, the prognosis of many patients with solid tumors is still dismal. Reliable noninvasive biomarkers are needed to predict patient survival and therapy response. Here, we propose a
Identifiants
pubmed: 38487624
doi: 10.1080/2162402X.2024.2328433
pii: 2328433
pmc: PMC10939156
doi:
Substances chimiques
Biomarkers
0
Autoantibodies
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2328433Informations de copyright
© 2024 The Author(s). Published with license by Taylor & Francis Group, LLC.
Déclaration de conflit d'intérêts
No potential conflict of interest was reported by the author(s).
Références
Front Immunol. 2015 May 26;6:257
pubmed: 26074922
PLoS One. 2021 Jun 16;16(6):e0252577
pubmed: 34133431
Methods Mol Biol. 2021;2227:191-203
pubmed: 33847943
Clin Cancer Res. 2010 Jun 15;16(12):3226-31
pubmed: 20515868
Cancer Immunol Res. 2019 Jul;7(7):1091-1105
pubmed: 31164356
Front Immunol. 2022 Nov 04;13:1039765
pubmed: 36420270
J Am Soc Nephrol. 2020 Apr;31(4):829-840
pubmed: 32034108
Front Immunol. 2019 Jan 29;10:64
pubmed: 30761135
Cell Metab. 2019 Jan 8;29(1):202-210.e6
pubmed: 30293775
Front Immunol. 2021 Apr 27;12:660382
pubmed: 33986750
Sci Rep. 2017 Nov 28;7(1):16456
pubmed: 29184132
J Am Soc Nephrol. 2017 May;28(5):1603-1613
pubmed: 28096309
Cancer Immunol Res. 2015 Dec;3(12):1325-32
pubmed: 26216416
Cancer Cell. 2022 Mar 14;40(3):240-243
pubmed: 35216677
Nature. 2021 Mar;591(7850):464-470
pubmed: 33536615
Arthritis Res Ther. 2017 Dec 06;19(1):266
pubmed: 29208014
Aging (Albany NY). 2020 Apr 28;12(8):7585-7602
pubmed: 32345771
Nature. 2015 May 7;521(7550):94-8
pubmed: 25924065
Mol Med Rep. 2015 Jun;11(6):4093-100
pubmed: 25673070
Int J Mol Sci. 2023 Mar 02;24(5):
pubmed: 36902242
Sci Immunol. 2021 Dec 24;6(66):eabf2489
pubmed: 34932384
Sci Immunol. 2021 Apr 7;6(58):
pubmed: 33827897
Cancer Immunol Res. 2021 Aug;9(8):891-908
pubmed: 34039653
J Immunol. 2020 Dec 1;205(11):3218-3229
pubmed: 33158953
Lupus Sci Med. 2019 Jun 03;6(1):e000326
pubmed: 31245016
Nephron. 1999 Jun;82(2):127-30
pubmed: 10364704
Cell Rep. 2016 May 17;15(7):1505-1513
pubmed: 27160908
Nat Rev Cancer. 2019 Dec;19(12):698-715
pubmed: 31666715
Antibodies (Basel). 2020 Oct 25;9(4):
pubmed: 33113844
Mol Cancer. 2021 Oct 20;20(1):136
pubmed: 34670568
Front Immunol. 2020 May 05;11:794
pubmed: 32431708
Clin Chim Acta. 2024 Feb 1;554:117750
pubmed: 38176523
Oncotarget. 2017 Dec 26;9(5):6346-6355
pubmed: 29464077
J Stat Softw. 2011 Mar;39(5):1-13
pubmed: 27065756
J Biol Chem. 2015 Oct 16;290(42):25343-55
pubmed: 26245903
Lab Invest. 2000 Mar;80(3):335-44
pubmed: 10744069
Cancer Immunol Res. 2021 Aug;9(8):909-925
pubmed: 34039652
Cancer Res. 2022 Mar 01;82(5):859-871
pubmed: 34949671
Neoplasma. 1994;41(4):229-32
pubmed: 7935998